Solid Biosciences (SLDB) Change in Cash (2017 - 2026)
Solid Biosciences (SLDB) reported Change in Cash of $236.6 million for Q1 2026, up 81.39% on a YoY basis from $130.4 million in Q1 2025, and up 17020.96% sequentially from -$1.4 million in Q4 2025.
Solid Biosciences (SLDB) Change in Cash (2017 - 2026) Analysis & Trends
Solid Biosciences (SLDB) has 10 years of Change in Cash data on file, last reported at $236.6 million in Q1 2026.
- For the quarter ending Q1 2026, Change in Cash rose 81.39% year-over-year to $236.6 million; the trailing twelve-month figure through Mar 2026 stood at $85.8 million (down 7.89% YoY), and the FY2025 full-year result was -$20.3 million, down 420.19% from the prior year.
- Change in Cash improved to $236.6 million in Q1 2026, from -$1.4 million in the prior quarter.
- In the past five years, Change in Cash ranged from a high of $236.6 million in Q1 2026 to a low of -$77.6 million in Q3 2025.
- A 5-year average of $10.4 million and a median of -$1.4 million in 2025 frame the typical range for Change in Cash.
- Across the five-year window, Change in Cash soared 1035.32% in 2022 and slumped 670.37% in 2023, its largest moves.
- Tracing SLDB's Change in Cash over 5 years: stood at $106.4 million in 2022, then tumbled by 76.51% to $25.0 million in 2023, then tumbled by 36.5% to $15.9 million in 2024, then slumped by 108.81% to -$1.4 million in 2025, then jumped by 17020.96% to $236.6 million in 2026.
- Business Quant data shows SLDB's Change in Cash at $236.6 million in Q1 2026, -$1.4 million in Q4 2025, and -$77.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -22.03 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 243.78 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.34 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 417.10 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -153.10 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 57.19 Mn |
| 10 | Solid Biosciences | 529.40 Mn | 529.40 Mn | - | 236.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 236.56 Mn |
| Dec 31, 2025 | -1.40 Mn |
| Sep 30, 2025 | -77.57 Mn |
| Jun 30, 2025 | -71.75 Mn |
| Mar 31, 2025 | 130.42 Mn |
| Dec 31, 2024 | 15.86 Mn |
| Sep 30, 2024 | -31.44 Mn |
| Jun 30, 2024 | -21.64 Mn |
| Mar 31, 2024 | 43.56 Mn |
| Dec 31, 2023 | 24.98 Mn |
| Sep 30, 2023 | -42.53 Mn |
| Jun 30, 2023 | -73.08 Mn |
| Mar 31, 2023 | 9.27 Mn |
| Dec 31, 2022 | 106.36 Mn |
| Sep 30, 2022 | -5.52 Mn |
| Jun 30, 2022 | -75.40 Mn |
| Mar 31, 2022 | 10.58 Mn |
| Dec 31, 2021 | 9.37 Mn |
| Sep 30, 2021 | -90.93 Mn |
| Jun 30, 2021 | -66.06 Mn |